[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hematology Analyzer Market: Analysis By Type (3-part, 5-part, 6-part), By Modality (POC, Standalone), By End User, By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)

December 2018 | 280 pages | ID: G8A3459DB51EN
Azoth Analytics

US$ 2,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
EXECUTIVE SUMMARY

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Hematology Analzyer Market. The report analyses the Hematology Analzyer Market By Type (3-Part, 5-Part, 6-Part), By Modality (Standalone Hematology Analyzer, Point-of-Care Hematology Analyzer) and By End Users (Hospitals, Diagnostics Laboratories and Other). The report assesses the Hematology Analzyer Market By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, & India). The Hematology Analzyer Market has been assessed for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Hematology Analyzer Market: Analysis By Type (3-part, 5-part, 6-part), By Modality (POC, Standalone), By End User, By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)”, the hematology analyzer market is projected to display a robust growth represented by a CAGR of 5.85% during 2018 – 2023.

Over the recent years, Hematology Analyzer market has been witnessing growth, on account of several driving factors including improvements in analytical capabilities, rise in demand for hematology analyzers with lesser operator intervention, increase in demand for POC hematology analyzers, and growing compatibility with electronic medical record system. Moreover, rapidly increasing number of hospitals and diagnostics laboratories due to surging prevalence of chronic diseases, cancer, vector borne diseases, and blood disorders have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in medical research has been contributing in the market growth of the hematology analyzers.

In this research report, the market is segmented on the basis of product type, modality as well as end user. By product type, the 3-part hematology analyzers are predicted to hold their dominant position in the market. By modality, standalone hematology analyzers are anticipated to creates their dominance in global hematology analyzer market, while POC hematology analyzers are expected to witness fastest growth. By end users, hospital segment is anticipated to provide the maximum revenue to the hematology analyzer manufacturers. Amongst the regions, North America accounts for the largest regional share in the global hematology market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.

The report titled “Global Hematology Analyzer Market: Analysis By Type (3-part, 5-part, 6-part), By Modality (POC, Standalone), By End User, By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)” has covered and analysed the potential of hematology analyzer market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the hematology analyzer market. Additionally, the report also highlights market entry strategies for various companies across the globe.

SCOPE OF THE REPORT

Global Hematology Analyzer Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Hematology Analyzer Market– Size, Growth, Forecast
  • Analysis By Type- 3-Part Differential Hematology Analyzer, 5-Part Differential Hematology Analyzer, 6-Part Differential Hematology Analyzer.
  • Analysis By Modality - Standalone Hematology Analyzer, Point-of-Care Hematology Analyzer.
  • Analysis By End Users - Hospitals, Diagnostics Laboratories, Others
Regional Market – North America, Europe, Asia Pacific, and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Hematology Analyzer Market– Size, Growth, Forecast
  • Analysis By Type- 3-Part Differential Hematology Analyzer, 5-Part Differential Hematology Analyzer, 6-Part Differential Hematology Analyzer.
  • Analysis By Modality - Standalone Hematology Analyzer, Point-of-Care Hematology Analyzer.
  • Analysis By End Users - Hospitals, Diagnostics Laboratories, Others
Country Analysis – U.S., Canada, Germany, U.K, France, Italy, China, Japan, India. (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Hematology Analyzer Market– Size, Growth, Forecast
  • Analysis By Type- 3-Part Differential Hematology Analyzer, 5-Part Differential Hematology Analyzer, 6-Part Differential Hematology Analyzer.
  • Analysis By Modality - Standalone Hematology Analyzer, Point-of-Care Hematology Analyzer.
  • Analysis By End Users - Hospitals, Diagnostics Laboratories, Others
Other Report Highlights
  • Market Dynamics – Drivers and Restraints.
  • Market Trends.
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Product Benchmarking.
  • Company Share.
  • Company Analysis - Sysmex, Nihon Kohden, Boule Diagnostics, HORIBA, Beckman Coulters, Abbott Laboratories, Siemens, EKF Diagnostics, Bio-Rad, Drew Scientific, BioSystems.
CUSTOMIZATION OF THE REPORT

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY

2. EXECUTIVE SUMMARY

3. STRATEGIC RECOMMENDATIONS

4. HEMATOLOGY ANALYZER PRODUCTS OUTLOOK

5. GLOBAL HEMATOLOGY ANALYZER MARKET: GROWTH AND FORECAST

5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. GLOBAL HEMATOLOGY ANALYZER MARKET: SEGMENT ANALYSIS

6.1 Global Hematology Analyzer Market Size, By Type: Breakdown (%)
  6.1.1 Global Hematology Analyzer Market Size, By Type, 2017 (%)
  6.1.2 Global Hematology Analyzer Market Size, By Type, 2023 (%)
6.2 Global 3-part Hematology Analyzer Market Size, By Value (2013-2023)
6.3 Global 5-part Hematology Analyzer Market Size, By Value (2013-2023)
6.4 Global 6-part Hematology Analyzer Market Size, By Value (2013-2023)
6.5 Global Hematology Analyzer Market Size, By Modality
  6.5.1 Global Standalone Hematology Analyzer Market Size, By Value (2013-2023)
  6.5.2 Global Point-of-Care Hematology Analyzer Market Size, By Value (2013-2023)
6.6 Global Hematology Analyzer Market Size, By End User
  6.6.1 Global Hospitals Hematology Analyzers Market Size, By Value (2013-2023)
  6.6.2 Global Diagnostics Laboratory Hematology Analyzer Market Size, By Value (2013-2023)
  6.6.3 Global Other Segments Hematology Analyzer Market Size, By Value (2013-2023)

7. GLOBAL HEMATOLOGY ANALYZER MARKET: COMPANY SHARE

8. GLOBAL HEMATOLOGY ANALYZER MARKET: MARKET ATTRACTIVENESS, BY PRODUCT TYPE

9. GLOBAL HEMATOLOGY ANALYZER MARKET: REGIONAL ANALYSIS

9.1 Global Hematology Analyzer Market Size, By Region: Breakdown (%)
  9.1.1 Global Hematology Analyzer Market Size, By Region, 2017 (%)
  9.1.2 Global Hematology Analyzer Market Size, By Region, 2023 (%)

10. NORTH AMERICA HEMATOLOGY ANALYZER MARKET: GROWTH AND FORECAST

10.1 North America Hematology Analyzer Market: Segment Analysis
10.2 North America Hematology Analyzer Market Size, By Type: Breakdown (%)
  10.2.1 North America Hematology Analyzer Market Size, By Type, 2017 (%)
  10.2.2 North America Hematology Analyzer Market Size, By Type, 2023 (%)
10.3 North America 3-part Hematology Analyzer Market Size, By Value (2013-2023)
10.4 North America 5-part Hematology Analyzer Market Size, By Value (2013-2023)
10.5 North America 6-part Hematology Analyzer Market Size, By Value (2013-2023)
10.6 North America Hematology Analyzer Market Size, By Modality
  10.6.1 North America Standalone Hematology Analyzer Size, By Value (2013-2023)
  10.6.2 North America Point-of-Care Hematology Analyzer Market Size, By Value (2013-2023)
10.7 North America Hematology Analyzer Market Size, By End User
  10.7.1 North America Hospitals Hematology Analyzer Market Size, By Value (2013-2023)
  10.7.2 North America Diagnostics Laboratory Hematology Analyzer Market Size, By Value (2013-2023)
  10.7.3 North America Other Segments Hematology Analyzer Market Size, By Value (2013-2023)
10.8 North America Hematology Analyzer Market: Country Analysis (U.S and Canada)
  10.8.1 U.S Hematology Analyzer Market, By Value (2013-2023)
  10.8.2 U.S Hematology Analyzer Market, By Type, By Value (2013-2023)
  10.8.3 U.S Hematology Analyzer Market, By End Users, By Value (2013-2023)
  10.8.4 Canada Hematology Analyzer Market, By Value (2013-2023)
  10.8.5 Canada Hematology Analyzer Market, By Type, By Value (2013-2023)
  10.8.6 Canada Hematology Analyzer Market, By End Users, By Value (2013-2023)

11. EUROPE HEMATOLOGY ANALYZER MARKET: GROWTH AND FORECAST

11.1 Europe Hematology Analyzer Market: Segment Analysis
11.2 Europe Hematology Analyzer Market Size, By Type: Breakdown (%)
  11.2.2 Europe Hematology Analyzer Market Size, By Type, 2017 (%)
  11.2.3 Europe Hematology Analyzer Market Size, By Type, 2023 (%)
11.3 Europe 3-Part Hematology Analyzer Market Size, By Value (2013-2023)
11.4 Europe 5-Part Hematology Analyzer Market Size, By Value (2013-2023)
11.5 Europe 6-Part Hematology Analyzer Market Size, By Value (2013-2023)
11.6 Europe Hematology Analyzer Market Size, By Modality: Breakdown(%)
  11.6.1 Europe Standalone Hematology Analyzer Market Size, By Value (2013-2023)
  11.6.2 Europe Point-of-Care Hematology Analyzer Market Size, By Value (2013-2023)
11.7 Europe Hematology Analyzer Market Size, By End User: Breakdown (%)
  11.7.1 Europe Hospitals Hematology Analyzer Market Size, By Value (2013-2023)
  11.7.2 Europe Diagnostics Laboratory Hematology Analyzer Market Size, By Value (2013-2023)
  11.7.3 Europe Other Segments Hematology Analyzer Market Size, By Value (2013-2023)
11.8 Europe Hematology Analyzer Market: Country Analysis (Germany, France, Italy, U.K)
  11.8.1 Germany Hematology Analyzer Market, By Value (2013-2023)
  11.8.2 Germany Hematology Analyzer Market, By Type, By Value (2013-2023)
  11.8.3 Germany Hematology Analyzer Market, By End Users, By Value (2013-2023)
  11.8.4 France Hematology Analyzer Market, By Value (2013-2023)
  11.8.5 France Hematology Analyzer Market, By Type, By Value (2013-2023)
  11.8.6 France Hematology Analyzer Market, By End Users, By Value (2013-2023)
  11.8.7 Italy Hematology Analyzer Market, By Value (2013-2023)
  11.8.8 Italy Hematology Analyzer Market, By Type, By Value (2013-2023)
  11.8.9 Italy Hematology Analyzer Market, By End Users, By Value (2013-2023)
  11.8.10 U.K Hematology Analyzer Market, By Value (2013-2023)
  11.8.11 U.K Hematology Analyzer Market, By Type, By Value (2013-2023)
  11.8.12 U.K Hematology Analyzer Market, By End Users, By Value (2013-2023)

12. APAC HEMATOLOGY ANALYZER MARKET: GROWTH AND FORECAST

12.1 APAC Hematology Analyzer Market: Segment Analysis
12.2 APAC Hematology Analyzer Market Size, By Type: Breakdown (%)
  12.2.1 APAC Hematology Analyzer Market Size, By Type, 2017 (%)
  12.2.2 APAC Hematology Analyzer Market Size, By Type, 2023 (%)
12.3 APAC 3-Part Hematology Analyzer Market Size, By Value (2013-2023)
12.4 APAC 5-Part Hematology Analyzer Market Size, By Value (2013-2023)
12.5 APAC 6-Part Hematology Analyzer Market Size, By Value (2013-2023)
12.6 APAC Hematology Analyzer Market Size, By Modality: Breakdown(%)
  12.6.1 APAC Standalone Hematology Analyzer Market Size, By Value (2013-2023)
  12.6.2 APAC Point-of-Care Hematology Analyzer Market Size, By Value (2013-2023)
12.7 APAC Hematology Analyzer Market Size, By End User: Breakdown (%)
  12.7.1 APAC Hospitals Hematology Analyzer Market Size, By Value (2013-2023)
  12.7.2 APAC Diagnostics Laboratory Hematology Analyzer Market Size, By Value (2013-2023)
  12.7.3 APAC Other Segments Hematology Analyzer Market Size, By Value (2013-2023)
12.8 APAC Hematology Analyzer Market: Country Analysis (Japan, China and India)
  12.8.1 Japan Hematology Analyzer Market, By Value (2013-2023)
  12.8.2 Japan Hematology Analyzer Market, By Type, By Value (2013-2023)
  12.8.3 Japan Hematology Analyzer Market, By End Users, By Value (2013-2023)
  12.8.4 China Hematology Analyzer Market, By Value (2013-2023)
  12.8.5 China Hematology Analyzer Market, By Type, By Value (2013-2023)
  12.8.6 China Hematology Analyzer Market, By End Users, By Value (2013-2023)
  12.8.7 India Hematology Analyzer Market, By Value (2013-2023)
  12.8.8 India Hematology Analyzer Market, By Type, By Value (2013-2023)
  12.8.9 India Hematology Analyzer Market, By End Users, By Value (2013-2023)

13. ROW HEMATOLOGY ANALYZER MARKET: GROWTH AND FORECAST

13.1 ROW Hematology Analyzer Market: Segment Analysis
13.2 ROW Hematology Analyzer Market Size, By Type: Breakdown (%)
  13.2.2 ROW Hematology Analyzer Market Size, By Type, 2017 (%)
  13.2.3 ROW Hematology Analyzer Market Size, By Type, 2023 (%)
13.3 ROW 3-Part Hematology Analyzer Market Size, By Value (2013-2023)
13.4 ROW 5-Part Hematology Analyzer Market Size, By Value (2013-2023)
13.5 ROW 6-Part Hematology Analyzer Market Size, By Value (2013-2023)
13.6 ROW Hematology Analyzer Market Size, By Modality: Breakdown(%)
  13.6.1 ROW Standalone Hematology Analyzer Market Size, By Value (2013-2023)
  13.6.2 ROW Point-of-Care Hematology Analyzer Market Size, By Value (2013-2023)
13.7 ROW Hematology Analyzer Market Size, By End User: Breakdown (%)
  13.7.1 ROW Hospitals Hematology Analyzer Market Size, By Value (2013-2023)
  13.7.2 ROW Diagnostics Laboratories Hematology Analyzer Market Size, By Value (2013-2023)
  13.7.3 ROW Other Segments Hematology Analyzer Market Size, By Value (2013-2023)

14. GLOBAL HEMATOLOGY ANALYZER MARKET: MARKET ATTRACTIVENESS, BY REGION

15. GLOBAL HEMATOLOGY ANALYZER MARKET: MARKET DYNAMICS

15.1 Global Hematology Analyzer Market Drivers
15.2 Global Hematology Analyzer Market Restrains
15.3 Global Hematology Analyzer Market Trends

16. PORTER FIVE FORCE ANALYSIS

17. SWOT ANALYSIS

18. COMPETITIVE LANDSCAPE: PRODUCT BENCHMARKING

19. GLOBAL HEMATOLOGY ANALYZER MARKET: REGULATORY FRAMEWORK

20. COMPANY PROFILES

20.1 Sysmex
20.2 Nihon Kohden
20.3 Boule Diagnostics
20.4 Horiba
20.5 Abbott Laboratories
20.6 Siemens
20.7 EFK Diagnostics
20.8 Bio-Rad
20.9 Backman Coulter
20.10 Bio Systems S.A.
20.11 Drew Scientific

LIST OF FIGURES

Figure 1: Global Hematology Analyzer Market Size, By Value, 2013-2017 (USD Million)
Figure 2: Number of New Cases of Cancer, In 2018, By Type, (% of Total)
Figure 3: Number of New Cases of Cancer, In 2018, By Region, (% of Total)
Figure 4: Prevalence of Diagnosed Autoimmune Diseases, In 2018, By Selected Countries, (% of Total)
Figure 5: Prevalence of Major Vector Borne Diseases, In 2017
Figure 6: Number of Blood Collection Centers in United States, 2013-2016
Figure 7: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016
Figure 8: Global IVD Vs POC Market Growth Rate, 2016-2022
Figure 9: Top Market Players in Point-Of-Care Hematology Analyzer Market
Figure 10: Causes of premature (under age 70) NCD mortality, 2017 (%)
Figure 11: Global Aged Population (Above 65), 2013-2017 (% of total)
Figure 12: Global Aged Population(Above 65), By Country, 2017 (% of total)
Figure 13: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 14: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 15: Global Expected Healthcare Industry Outlook
Figure 16: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 17: Global Hematology Analyzer Market Size, By Value, Forecast, 2018-2023 (USD Million)
Figure 18: Global Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 19: Global Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 20: Global 3-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 21: Global 3-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 22: Global 5-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 23: Global 5-Part Differential Hematology Analyzer Market, 2018-2023(USD Million)
Figure 24: Global 6-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 25: Global 6-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 26: Market Comparison Chart, By Product Type, 2013-2023 (USD Million)
Figure 27: Global Market Attractiveness, By Product Type, 2023F
Figure 28: Global Hematology Analyzer Market Size, By Modality, 2017 (%)
Figure 29: Global Hematology Analyzer Market Size, By Modality, 2023F (%)
Figure 30: Global Hematology Analyzer Market, By Modality, By Value, 2013-2017 (USD Million)
Figure 31: Global Hematology Analyzer Market, By Modality, By Value, 2018-2023(USD Million)
Figure 32: Global Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 33: Global Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 34: Global Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 35: Global Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 36: Global Hematology Analyzer Market Size, By Region, 2017 (%)
Figure 37: Global Hematology Analyzer Market Size, By Region, 2023F (%)
Figure 38: North America Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 39: Number of People Living With Blood Cancer in Canada, 2016
Figure 40: Number of Blood Cancer Cases in United States, 2018
Figure 41: North America Diseases Outlook
Figure 42: United States health care expenditure per capita,2013-2016(USD)
Figure 43: United States health care expenditure per capita,2013-2016(USD)
Figure 44: North America population aged 65 and above, 2013-2017 (% of total)
Figure 45: North America Healthcare Cost Per Capita, 2017 (USD)
Figure 46: North America GDP per Capita, 2013-2017 (USD)
Figure 47: North America Hematology Analyzer Market, By Value, 2018-2023 (USD Million)
Figure 48: North America Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 49: North America Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 50: North America 3-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 51: North America 3-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 52: North America 5-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 53: North America 5-Part Differential Hematology Analyzer Market, 2018-2023(USD Million)
Figure 54: North America 6-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 55: North America 6-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 56: North America Hematology Analyzer Market Size, By Modality, 2017 (%)
Figure 57: North America Hematology Analyzer Market Size, By Modality, 2023F (%)
Figure 58: North America Hematology Analyzer Market, By Modality, By Value, 2013-2017 (USD Million)
Figure 59: North America Hematology Analyzer Market, By Modality, By Value, 2018-2023(USD Million)
Figure 60: North America Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 61: North America Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 62: North America Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 63: North America Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 64: North America Hematology Analyzer Market Size, By Countries, 2017 (%)
Figure 65: North America Hematology Analyzer Market Size, By Countries, 2023F (%)
Figure 66: USA Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 67: USA Hematology Analyzer Market, By Value,2018-2023(USD Million)
Figure 68: Medical and Healthcare Research & Development Spending, 2013-2016 (In USD Million)
Figure 69: Number of Different Types of Laboratories in Unites States, 2018
Figure 70: Number of People Living With Different Type of Blood Cancers in US
Figure 71: Medical Infrastructure Outlook in USA
Figure 72: U.S., Population ages 65 and above, 2013-2017 (% of total)
Figure 73: U.S., Population ages 65 and above, Forecast (In Millions)
Figure 74: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 75: U.S., GDP (Current USD), 2013-2017 (In USD Trillion)
Figure 76: Leading Hematology Analyzer Companies In The United States of America
Figure 77: Leading Medical Laboratories In The United States of America
Figure 78: USA Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 79: USA Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 80: USA Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 81: USA Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 82: USA Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 83: USA Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 84: USA Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 85: Canada Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 86: Canada Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 87: Work Setting of Hematologists in Canada, 2018
Figure 88: Number Hospitals Establishments in Canada, By Province, 2015
Figure 89: New Blood Cancer Cases in Canada, 2018, (% of Total)
Figure 90: Canada Diseases and Blood Donation Outlook, 2017
Figure 91: Prevalence of Diabetics in Canada, (% of Total Population) 2015 & 2045E
Figure 92: Estimated Prevalence of Pre-Diabetics in Canada, (% of Total Population) 2015 & 2045E
Figure 93: Overweight and Obese Population in Canada, 2015-2017 (% of total)
Figure 94: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Figure 95: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Figure 96: Canada, Population ages 65 and above, 2012-2017 (% of total)
Figure 97: Leading Hematology Analyzer Companies In Canada
Figure 98: Leading Medical Laboratories & Research Institutes In Canada
Figure 99: Canada Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 100: Canada Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 101: Canada Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 102: Canada Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 103: Canada Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 104: Canada Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 105: Canada Hematology Analyzer Market, By End User, By Value, 201-2023 (USD Million)
Figure 106: Europe Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 107: EU-5 Socio-Economical Statistics, 2017
Figure 108: Europe Health Expenditure, By Select Country, 2016 (% of GDP)
Figure 109: Europe Population ages 65 years and above (% of total population), 2013-17
Figure 110: Prevalence of Diabetes (Age 18+), 2017 & 2045E(In Million)
Figure 111: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Figure 112: Cause of Death, EU-28, 2015, Per 1000000 inhabitants, Both Sex
Figure 113: Europe Hematology Analyzer Market, By Value, 2018-2023 (USD Million)
Figure 114: Europe Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 115: Europe Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 116: Europe 3-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 117: Europe 3-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 118: Europe 5-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 119: Europe 5-Part Differential Hematology Analyzer Market, 2018-2023(USD Million)
Figure 120: Europe 6-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 121: Europe 6-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 122: Europe Hematology Analyzer Market Size, By Modality, 2017 (%)
Figure 123: Europe Hematology Analyzer Market Size, By Modality, 2023F (%)
Figure 124: Europe Hematology Analyzer Market, By Modality, By Value, 2013-2017 (USD Million)
Figure 125: Europe Hematology Analyzer Market, By Modality, By Value, 2018-2023(USD Million)
Figure 126: Europe Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 127: Europe Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 128: Europe Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 129: Europe Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 130: Europe Hematology Analyzer Market Size, By Countries, 2017 (%)
Figure 131: Europe Hematology Analyzer Market Size, By Countries, 2023F (%)
Figure 132: Germany Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 133: Germany Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 134: Germany, Leukemia Incidences, 2014 & 2018E
Figure 135: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 136: Germany, Cause of Deaths, Percentage Change,2007-2017
Figure 137: Germany, Spending on Healthcare, 2015 & 2040E, (USD Per Person)
Figure 138: Germany Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 139: Germany Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 140: Germany Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 141: Germany Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 142: Germany Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 143: Germany Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 144: Germany Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 145: Leading Hematology Analyzer Companies In Germany
Figure 146: Leading Medical Laboratories In Germany
Figure 147: France Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 148: France Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 149: France, Healthcare Infrastructure Related Statistics
Figure 150: France, Health Expenditure, (% of GDP), 2012-2015 (USD)
Figure 151: France, Population Ages 65 and Above (% of total), 2012-2017
Figure 152: France, Prevalence of Cancer, 2018, (% of total)
Figure 153: France, Spending on Healthcare, 2015 & 2040$, (USD Per Person)
Figure 154: France, Cause of Death, Percentage Change Between 2007-2017
Figure 155: France Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 156: France Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 157: France Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 158: France Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 159: France Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 160: France Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 161: France Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 162: Leading Hematology Analyzer Companies In France
Figure 163: Italy Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 164: Italy Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 165: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
Figure 166: Italy, Population Ages 65 and Above (% of total), 2012-2017
Figure 167: Italy, Healthcare Infrastructure Related Statistics
Figure 168: Italy, Prevalence of Cancer, 2018, (% of Total)
Figure 169: Italy, Prevalence of Cancer, 2018, (% of Total)
Figure 170: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Figure 171: Italy, Cause of Death, Percentage Change Between 2007-2017
Figure 172: Italy Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 173: Italy Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 174: Italy Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 175: Italy Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 176: Italy Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 177: Leading Hematology Analyzer Companies In Italy
Figure 178: Leading Medical Laboratories In Italy
Figure 179: Italy Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 180: Italy Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 181: U.K Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 182: U.K Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 183: Italy, Healthcare Infrastructure Related Statistics
Figure 184: U.K, Health Expenditure, (% of GDP), 2013-2017 (USD)
Figure 185: U.K, Population Ages 65 and Above (% of total), 2012-2017
Figure 186: U.K, Prevalence of Cancer, 2018, (% of Total)
Figure 187: U.K, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Figure 188: U.K, Cause of Death, Percentage Change Between 2007-2017
Figure 189: U.K Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 190: U.K Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 191: U.K Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 192: U.K Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 193: U.K Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 194: U.K Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 195: U.K Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 196: Leading Hematology Analyzer Companies In U.K
Figure 197: Leading Medical Laboratories In U.K
Figure 198: APAC Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 199: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Figure 200: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 201: Diabetes Prevalence (% of population ages 20 to 79), By Selected Country, 2017
Figure 202: Obesity Rate, By Selected Country, 2017 (In Percentage)
Figure 203: Cancer Incidences in Asia, (% of Total), 2018
Figure 204: Share of Malaria Cases in South East Asia, 2016, (% 0f total)
Figure 205: APAC Hematology Analyzer Market, By Value, 2018-2023 (USD Million)
Figure 206: APAC Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 207: APAC Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 208: APAC 3-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 209: APAC 3-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 210: APAC 5-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 211: APAC 5-Part Differential Hematology Analyzer Market, 2018-2023(USD Million)
Figure 212: APAC 6-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 213: APAC 6-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 214: APAC Hematology Analyzer Market Size, By Modality, 2017 (%)
Figure 215: APAC Hematology Analyzer Market Size, By Modality, 2023F (%)
Figure 216: APAC Hematology Analyzer Market, By Modality, By Value, 2013-2017 (USD Million)
Figure 217: APAC Hematology Analyzer Market, By Modality, By Value, 2018-2023(USD Million)
Figure 218: APAC Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 219: APAC Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 220: APAC Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 221: APAC Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 222: APAC Hematology Analyzer Market Size, By Countries, 2017 (%)
Figure 223: APAC Hematology Analyzer Market Size, By Countries, 2023F (%)
Figure 224: Japan Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 225: Japan Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 226: Japan, Cause of Death, Percentage Change Between 2007-2017
Figure 227: Japan, Healthcare Outlook
Figure 228: Japan, Cancer Prevalence, By Type, (2018)
Figure 229: Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 230: Japan Healthcare Expenditure Outlook (%)
Figure 231: Japan, Population ages 65 and above, 2012-2016 (% of total)
Figure 232: Japan Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 233: Japan Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 234: Japan Hematology Analyzer Market By Type, By Value, 2013-2017 (USD Million)
Figure 235: Japan Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 236: Japan Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 237: Japan Hematology Analyzer Market By End User, By Value, 2013-2017 (USD Million)
Figure 238: Japan Hematology Analyzer Market By End User, By Value, 2018-2023 (USD Million)
Figure 239: Leading Hematology Analyzer Companies In Japan
Figure 240: Leading Medical Laboratories In Japan
Figure 241: China Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 242: China Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 243: China, Cancer Incidences ( in Million)
Figure 244: China, Cause of Death, Percentage Change Between 2007-2017
Figure 245: China, Healthcare Outlook
Figure 246: China, Cancer Prevalence, By Type, (2018)
Figure 247: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 248: China, Share of Urban Population, 2012-2017 (In %)
Figure 249: China, Total Population, 2013-2021F (In Billion)
Figure 250: China Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 251: China Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 252: China Hematology Analyzer Market, By Type, By Value, 2013-2017 (USD Million)
Figure 253: China Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 254: China Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 255: China Hematology Analyzer Market, By End User, By Value, 2013-2017 (USD Million)
Figure 256: China Hematology Analyzer Market, By End User, By Value, 2018-2023(USD Million)
Figure 257: Leading Hematology Analyzer Companies In China
Figure 258: Leading Medical Laboratories In China
Figure 259: India Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 260: India Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 261: India, Blood Disorders Incidences in Children, By Type
Figure 262: India, Diseases Outlook
Figure 263: India, Population ages 65 and above, 2013-2017
Figure 264: India, Total Population, 2013-2023F (In Billion)
Figure 265: India, Medical Industry Outlook
Figure 266: India Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 267: India Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 268: India Hematology Analyzer Market By Type, By Value, 2013-2017 (USD Million)
Figure 269: India Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 270: India Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 271: India Hematology Analyzer Market By End User, By Value, 2013-2017 (USD Million)
Figure 272: India Hematology Analyzer Market By End User, By Value, 2018-2023(USD Million)
Figure 273: Leading Hematology Analyzer Companies In India
Figure 274: Leading Medical Laboratories In India
Figure 275: ROW Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 276: Malaria Prevalence in West Africa, (% of total), 2017
Figure 277: Malaria Prevalence in South and East Africa, (% of total), 2017
Figure 278: Malaria in Middle Eastern Region, (% of total), 2017
Figure 279: Cancer Prevalence in MENA (% of total), 2018
Figure 280: Cancer Prevalence in Latin America & Caribbean, (% of total), 2018
Figure 281: GDP Per Capita in ROW, By Select Country, 2013 (In USD)
Figure 282: GDP Per Capita in ROW, By Select Country, 2017 (In USD)
Figure 283: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total)
Figure 284: Middle East and North Africa, Population ages 65 and above (% of total)
Figure 285: ROW Hematology Analyzer Market, By Value, 2018-2023 (USD Million)
Figure 286: ROW Hematology Analyzer Market Size, By Type, 2017 (%)
Figure 287: ROW Hematology Analyzer Market Size, By Type, 2023F (%)
Figure 288: ROW 3-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 289: ROW 3-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 290: ROW 5-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 291: ROW 5-Part Differential Hematology Analyzer Market, 2018-2023(USD Million)
Figure 292: ROW 6-Part Differential Hematology Analyzer Market, By Value, 2013-2017 (USD Million)
Figure 293: ROW 6-Part Differential Hematology Analyzer Market, By Value, 2018-2023(USD Million)
Figure 294: ROW Hematology Analyzer Market Size, By Modality, 2017 (%)
Figure 295: ROW Hematology Analyzer Market Size, By Modality, 2023F (%)
Figure 296: ROW Hematology Analyzer Market By Modality, By Value, 2013-2017 (USD Million)
Figure 297: ROW Hematology Analyzer Market By Modality, By Value, 2018-2023(USD Million)
Figure 298: ROW Hematology Analyzer Market Size, By End User, 2017 (%)
Figure 299: ROW Hematology Analyzer Market Size, By End User, 2023F (%)
Figure 300: ROW Hematology Analyzer Market By End User, By Value, 2013-2017 (USD Million)
Figure 301: ROW Hematology Analyzer Market By End User, By Value, 2018-2023(USD Million)
Figure 302: Global Market Attractiveness, By Region, 2023F
Figure 303: Sysmex, Revenues 2013-2017(USD Million)
Figure 304: Sysmex, Revenues, By Region, 2017(%)
Figure 305: Sysmex, Revenues, By Segments, 2017(%)
Figure 306: Sysmex, Revenues, By Americas Region, 2017(%)
Figure 307: Sysmex, Sales in Americas, By Segments, 2017(%)
Figure 308: Sysmex, EMEA Revenues, By Region, 2017(%)
Figure 309: Sysmex, Sales in EMEA, By Segments, 2017(%)
Figure 310: Sysmex, APAC Revenues, By Region, 2017(%)
Figure 311: Sysmex, Sales in APAC, By Segments, 2017(%)
Figure 312: Nihon Kohden, Net Sales, 2013-2017 (USD Billion)
Figure 313: Nihon Kohden, Revenue, By Segments, 2017(%)
Figure 314: Nihon Kohden, Revenue, By Regions, 2017 (%)
Figure 315: Boule Diagnostics, Revenues, 2013-2017 (USD Million)
Figure 316: Boule Diagnostics, Revenue, By Segments, 2017(%)
Figure 317: Boule Diagnostics, Revenue, By Segment, 2017 (USD Million)
Figure 318: Horiba, Net Sales, 2013-2017 (USD Million)
Figure 319: Horiba, Revenue, By Segment, 2017(%)
Figure 320: Horiba, Net Sales, Medical & Diagnostics, 2013-2017 (USD Million)
Figure 321: Horiba, Revenue, By Medical & Diagnostics Segment, 2017(%)
Figure 322: Abbott Laboratories, Net Sales, 2013-2017 (USD Million)
Figure 323: Abbott Laboratories, Revenue, By Segments, 2017(%)
Figure 324: Abbott Laboratories, Revenue, By Regions, 2017(%)
Figure 325: Siemens, Net Sales, 2013-2017 (USD Million)
Figure 326: Siemens, Revenue, By Regions, 2017(%)
Figure 327: Siemens, Revenue, By Segments, 2017(%)
Figure 328: EFK Diagnostics, Net Sales, 2013-2017 (USD Million)
Figure 329: EKF Diagnostics, Revenue, By Regions, 2017(%)
Figure 330: Bio-Rad, Net Sales, 2013-2017 (USD Million)
Figure 331: Bio-Rad Revenue, By Region, 2017(%)
Figure 332: Bio-Rad Revenue, By Segment, 2017(%)

LIST OF TABLES

Table A: Difference Between 3 & 5 Part Differential Hematology Analyzers
Table B: Difference Between Semi-Automated and Fully-Automated Hematology Analyzers
Table C: Germany, Healthcare Related Statistics, 2017
Table D: Germany, Prevalence of Cancer, 2018 (% of total)
Table E: Percentage aged 60 years and over, (2000, 2015, 2030,2050)
Table F: Hematology Analyzer - Product Benchmarking


More Publications